Cancer Trials in Kashiwa-shi, Japan
Conditions / Cancer / Kashiwa-shi, Japan
Research into Cancer spans multiple therapeutic approaches and trial phases.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04198415 | A Study of the Safety and Efficacy of Venetoclax in Japanese Participants With Relapsed and Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Leukemia) | COMPLETED | — |
| NCT04178902 | A Study of the Safety and Tolerability of ABBV-467 in Adult Participants With Relapsed/Refractory (R/R) Multiple Myeloma | TERMINATED | PHASE1 |
| NCT04272203 | A Study to Determine Safety, Tolerability, Pharmacokinetics, and Recommended Phase 2 Dose (RP2D) of Intravenous ABBV-184 in Adult Participants With Previously Treated Cancers | TERMINATED | PHASE1 |
| NCT03082209 | A Study of the Safety and Tolerability of ABBV-621 in Participants With Previously-Treated Solid Tumors and Hematologic Malignancies | COMPLETED | PHASE1 |
| NCT05061823 | Bintrafusp Alfa Program Rollover Study | COMPLETED | PHASE3 |
| NCT05862285 | A Rollover Study for Participants Previously Enrolled in a Genentech and/or F. Hoffman-La Roche Sponsored Study | RECRUITING | PHASE3 |
| NCT04189614 | An Efficacy and Safety Study of Cofetuzumab Pelidotin in Participants With PTK7-Expressing, Recurrent Non-Small Cell Lung Cancer | ACTIVE_NOT_RECRUITING | PHASE1 |
| NCT01413906 | Phase 1 Multiple Ascending Dose Study of BMS-833923 (XL139) in Subjects With Solid Tumors | COMPLETED | PHASE1 |
| NCT03899155 | Pan Tumor Rollover Study | RECRUITING | PHASE2 |
| NCT02966548 | Safety Study of BMS-986016 With or Without Nivolumab in Patients With Advanced Solid Tumors | COMPLETED | PHASE1 |